Device Trial Radar · NCT05732818
Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy 3
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
50
Planned (sponsor's estimate)
Start
Jun 16, 2023
Primary completion
Sep 16, 2027
Study completion Jun 16, 2028
Sponsor
- Lead sponsor
- Spinal Stabilization TechnologiesNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Raylytic GmbH
- First posted
- Feb 17, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a First in Human, prospective, multi-center clinical study intended to collect safety and performance information for the Spinal Stabilization Technologies PerQdisc® Nucleus Replacement System and procedure concurrently following a successful discectomy using a minimally invasive posterolateral (MIPL) approach. Patients that are at least 21 years or older, presenting with symptomatic radiculopathy from a focal lumbar disc herniation that requires surgical decompression will be included in this study.
Conditions
- Back Pain With Radiation
- Radiculopathy
- Back Pain
- Disc Herniation
- Herniated Nucleus Pulposus
- Herniated Disc
- Disc Injury
- Disk Herniated Lumbar
Interventions
PerQdisc Nucleus Replacement SystemDevice
Lumbar spine disc nucleus replacement system. All patients meeting all inclusion criteria and no exclusion criteria will be considered for nucleus replacement surgery following a review by the Medical Advisory Board.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety: Number of Patients with Serious Adverse Events related to the PerQdiscTime frame: 12 months
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Sanatorio Americano
Asunción, Paraguay
Republican Specialized Scientific Practical Medical Center of Endocrinology named after Academician Y.Kh. Turakulova
Tashkent, Tashkent, Uzbekistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.